Endocrinology and metabolism Archives - Page 5 of 6

Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: a review of the literature

Authors: C J Alleman, K Y Westerhout, M Hensen, C Chambers, M Stoker, S Long, F E van Nooten Published: Diabetes Research and Clinical Practice, 2015 View publication Aims Painful diabetic peripheral...

Cost-effectiveness analysis of rivaroxaban in the secondary prevention of acute coronary syndromes in Sweden

Authors: N Begum, S Stephens, O Schoeman, A Fraschke, B Kirsch, J B Briere, F W Verheugt, B van Hout Published: Cardiology and Therapy, 2015 View publication Background Worldwide, coronary heart disease...

Cost-effectiveness analysis of exenatide once-weekly versus dulaglutide, liraglutide, and lixisenatide for the treatment of type 2 diabetes mellitus: an analysis from the UK NHS perspective.

Authors: L H Chuang, B Verheggen, M Charokopou, D Gibson, S Grandy, B Kartman Published: Journal of Medical Economics, 2016 View publication Objective To assess the cost-effectiveness of exenatide 2?mg once-weekly (EQW)...

Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis

Authors: C T Solem, M Vera-Llonch, S Liu, M Botteman, B Castiglione Published: Health and Quality of Life Outcomes, 2016 View publication Background The analysis aimed to examine the impact of pulmonary...

Trajectories of depressive symptoms in community-dwelling older adults: A six-month longitudinal study with monthly assessment

Authors: S Fishleder, A M Gum, B L King-Kallimanis, L Schonfeld Published: Journal of Affective Disorders, 2016 View publication Background This study aimed to examine six-month trajectories of depressive symptoms and their...

Cost effectiveness analysis of fesoterodine compared to mirabegron in first-line therapy setting for overactive bladder with urge urinary incontinence, from the Spanish National Health System perspective

Authors: J C Angulo, F Sánchez-Ballester, C Peral, J Rejas, J Ramos, S J Snedecor, L Sudharshan, S Liu, X Luo Published: Actas Urologicas Espanolas, 2016 View publication Objectives To evaluate the...

Treatment patterns, symptom reduction, quality of life, and resource use associated with lubiprostone in irritable bowel syndrome constipation subtype

Authors: C T Solem, H Patel, S Mehta, R Mody, C Macahilig, X Gao Published: Current Medical Research and Opinion, 2016 View publication Abstract Objectives Real-world patient outcomes data is scarce concerning...

Patient and physician preferences for oral pharmacotherapy for overactive bladder: two discrete choice experiments

Authors: M Heisen, S A Baeten, B G Verheggen, M Stoelzel, Z Hakimi, A Ridder, R van Maanen, E A Stolk Published: Current Medical Research and Opinion, 2016 View publication Objective We...

Evaluating drug cost per response with SGLT2 inhibitors in patients with type 2 diabetes mellitus

Authors: J M Lopez, B Macomson, V Ektare, D Patel, M Botteman Published: American Health and Drug Benefits, 2015 View publication Background The sodium-glucose cotransporter 2 (SGLT2) inhibitors, which include canagliflozin, dapagliflozin,...

News